Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yajun Guo

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
Mabs|February 14, 2012
Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjectsBo Zhou, Birong Lin, Jing Li, et al.
Mabs|January 14, 2016
Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacyYun Yang, Qingcheng Guo, Xi Chen, et al.
Cancer Research|August 3, 2002
Impaired infiltration of tumor-specific cytolytic T cells in the absence of interferon-gamma despite their normal maturation in lymphoid organs during CD137 monoclonal antibody therapyRyan A Wilcox, Dallas B Flies, Hao Wang, et al.
Molecular Immunology|July 9, 2011
Clearance of Propionibacterium acnes by kupffer cells is regulated by osteopontin through modulating the expression of p47phoxHaiou Yang, Huaizu Guo, Kexing Fan, et al.
Biomaterials|March 8, 2011
The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumorsWei Li, Jinfeng Li, Jie Gao, et al.
Biochemical and Biophysical Research Communications|April 25, 2007
Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibodyBohua Li, Hao Wang, Dapeng Zhang, et al.
The Journal of Biological Chemistry|March 19, 2013
Structural basis for treating tumor necrosis factor α (TNFα)-associated diseases with the therapeutic antibody infliximabShuaiyi Liang, Jianxin Dai, Sheng Hou, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2007
Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndromeHao Wang, Shuichuan Song, Geng Kou, et al.
Cancer Research|November 16, 2014
Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesisXiaoyu Fan, Chunyan He, Wei Jing, et al.
Plos One|December 25, 2013
Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatinHuafeng Wei, Likun Zhao, Wei Li, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Mabs|February 14, 2012
Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjectsBo Zhou, Birong Lin, Jing Li, et al.
Mabs|January 14, 2016
Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacyYun Yang, Qingcheng Guo, Xi Chen, et al.
Cancer Research|August 3, 2002
Impaired infiltration of tumor-specific cytolytic T cells in the absence of interferon-gamma despite their normal maturation in lymphoid organs during CD137 monoclonal antibody therapyRyan A Wilcox, Dallas B Flies, Hao Wang, et al.
Molecular Immunology|July 9, 2011
Clearance of Propionibacterium acnes by kupffer cells is regulated by osteopontin through modulating the expression of p47phoxHaiou Yang, Huaizu Guo, Kexing Fan, et al.
Biomaterials|March 8, 2011
The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumorsWei Li, Jinfeng Li, Jie Gao, et al.
Biochemical and Biophysical Research Communications|April 25, 2007
Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibodyBohua Li, Hao Wang, Dapeng Zhang, et al.
The Journal of Biological Chemistry|March 19, 2013
Structural basis for treating tumor necrosis factor α (TNFα)-associated diseases with the therapeutic antibody infliximabShuaiyi Liang, Jianxin Dai, Sheng Hou, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2007
Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndromeHao Wang, Shuichuan Song, Geng Kou, et al.
Cancer Research|November 16, 2014
Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesisXiaoyu Fan, Chunyan He, Wei Jing, et al.
Plos One|December 25, 2013
Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatinHuafeng Wei, Likun Zhao, Wei Li, et al.
Pageof 22